Now showing items 1-2 of 2

    • Host markers in Quantiferon supernatants differentiate active TB from latent TB infection : preliminary report 

      Chegou, Novel N.; Black, Gillian F.; Kidd, Martin; Van Helden, Paul D.; Walzl, Gerhard (BioMed Central, 2009-05)
      Background: Interferon gamma release assays, including the QuantiFERON® TB Gold In Tube (QFT) have been shown to be accurate in diagnosing Mycobacterium tuberculosis infection. These assays however, do not discriminate ...

    • A metabolic biosignature of early response to anti-tuberculosis treatment 

      Mahapatra, Sebabrata; Hess, Ann M.; Johnson, John L.; Eisenach, Kathleen D.; DeGroote, Mary A.; Gitta, Phineas; Joloba, Moses L.; Kaplan, Gilla; Walzl, Gerhard; Boom, W. H.; Belisle, John T. (BioMed Central, 2014-01)
      Background The successful treatment of tuberculosis (TB) requires long-term multidrug chemotherapy. Clinical trials to evaluate new drugs and regimens for TB treatment are protracted due to the slow clearance ...